Loading…

Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study

In the original publication, Figure 3 showed an upward directed arrow for improvement in the monthly migraine headache days. However, the direction of the arrow has been corrected to downward direction, to present the improvement in monthly migraine headache days.

Saved in:
Bibliographic Details
Published in:Quality of life research 2021-02, Vol.30 (2), p.465-466
Main Authors: Ford, Janet H., Stauffer, Virginia L., McAllister, Peter, Akkala, Sreelatha, Sexson, Matthew, Ayer, David W., Wang, Shufang
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the original publication, Figure 3 showed an upward directed arrow for improvement in the monthly migraine headache days. However, the direction of the arrow has been corrected to downward direction, to present the improvement in monthly migraine headache days.
ISSN:0962-9343
1573-2649
DOI:10.1007/s11136-020-02720-1